Frequently Asked Questions for Clinicians
Answers to clinicians’ questions – ranging from how Genecept works, to ordering, test cost, and more.
How does the Genomind® Genecept Assay® work?
It is a pharmacogenetic test designed to help clinicians optimize treatment decisions for their patients with mental illness. It identifies patient-specific genetic markers that indicate which treatments are likely to work as intended, have no effect, or cause adverse effects. It is an easily administered cheek swab test that analyzes key genes, selected based on hundreds of studies showing that variations in these genes can inform treatment decisions. The Genomind Genecept Assay is used to guide treatment for a range of psychiatric conditions including depression, anxiety, obsessive-compulsive disorder (OCD), attention deficit hyperactivity disorder (ADHD), bipolar disorder, post traumatic stress disorder (PTSD), autism, schizophrenia, chronic pain and substance abuse. Each Assay provides clinicians with an easy to read patient report and a complimentary psychopharmacologist consultation.
Watch a short overview
How do I order the Genomind Genecept Assay for a patient?
The Genomind Genecept Assay is commercially available for use by any licensed, prescribing clinician. Clinicians may order a test kit by completing our online order form or by calling us at:
Patients should discuss with their clinician whether the Genomind Genecept Assay is right for them before being tested.
How much will the Genomind Genecept Assay cost my patient?
The Genomind Genecept Assay is submitted for reimbursement to commercial and third-party payers, Medicare, and some other government programs. Genomind has also created a Patient Assistance Program for those who qualify. (US residents only). Genomind is committed to making our testing accessible for all patients. If your patient has any specific insurance, billing or financial questions or concerns, please have them contact Genomind directly at:
If you live outside of the US – Please contact us to find out how we can help
Does Medicare cover the Genomind Genecept Assay?
Medicare reimburses for the CYP2D6 gene analysis portion of the Genomind Genecept Assay. This portion of the test is covered when the clinician is considering an initial therapy of amitriptyline or nortriptyline for treatment of depressive disorders, or tetrabenazine doses greater than 50 mg/day, or re-initiation of this therapy with doses greater than 50 mg/day. The patient must have a diagnosis of major depressive disorder or bipolar disorder. For additional information, please reference www.cms.gov.
How quickly will the clinician receive the test results?
The test results will be provided to the ordering clinician in approximately 3-5 business days after we have received the patient’s cheek swab sample at the lab and all paperwork has been validated. Test results are available via our simple and secure online Clinician Portal.
How does the clinician use the report?
The Genomind Genecept Assay report is intended to aid clinicians in making personalized treatment decisions tailored to a patient’s genetic background and helps to inform psychiatric treatments that:
- Are more likely to be effective
- Have lower risk for side effects and adverse events
- Are dosed appropriately
The clinician can use the report to help select the most appropriate class of medication(s) to use, as well as to help with dosing. Please see our Sample Results page for more details. In addition, included with every patient test is access to Genomind’s expert staff, enabling you to consult with a Genomind physician or pharmacist to help determine optimal treatment.
What recommendations will be offered?
The Genomind Genecept Assay does not make treatment recommendations. We offer information about your patient’s potential neurochemistry and drug metabolism that can help inform your treatment decisions. You can expect to see information about the specific genetic makeup of your patient based on our test. This information, along with your patient’s medical history, can help you to tailor your treatment decisions.
Can the clinician get assistance in interpreting the test results?
Yes, included with every patient test is access to Genomind’s expert staff, enabling you to consult with a Genomind physician or pharmacist to help determine optimal treatment. They will be able to answer any questions you may have regarding the report and specific test results.
Why did you choose to include the genes that you have in the Genomind Genecept Assay?
Our clinical research and development team has chosen to include a comprehensive group of key genes to make up the Genomind Genecept Assay. These genes were selected based on hundreds of studies showing that variations in these genes can inform treatment decisions in psychiatry. For a summary of the peer reviewed, published literature supporting the inclusion of these genes in our test, and also cited in every patient report, please request our Literature Summary from our Customer Service team at firstname.lastname@example.org.
As we enter a new age of medicine, applying genetics and understanding more of the underpinnings of illness, it is helpful to have a reliable, consistent partner like Genomind. For the last two years, we have been ordering the Genecept Assay® on new and existing patients in our clinic, and recently I commented that I feel at a disadvantage when I don’t have access to my patient’s genetic information. Although genetic testing is not diagnostic of illness it is helpful for clinicians and patients alike. Genetic testing aids in the understanding the multitude of complex factors that coexist to cause symptoms, and certainly is helpful in planning for effective treatment which helps us get patients to remission.